Deprescribing for Older Adults Flashcards

1
Q

Barriers to deprescribing

A

Sociocultural: Medical culture of prescribing
Relational: Uncertainty, fear/accountability, professional relationships
Organizational: Limited time, no targeted funding, care fragmentation
Individual: Patient uncertainty, “Doctor knows best”, impaired cognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Facilitators of Deprescribing

A

Sociocultural: Acknowledging the complexity of multi-morbidity and frailty, less is sometimes more
Relational: Continuity of care, mechanisms for communication between providers
Organizational: Reimbursement for deprescribing, access to support resources
Individual: Awareness of potential harms of continuation, discuss goals of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Process of deprescribing

A

Comprehensive medication history
Identify potentially inappropriate medication
Determine eligibility for deprescribing and prioritize
Plan and initiate withdrawal
Monitor, support, and document

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Potential drug-induced harm: drug factors

A

Number of medications prescribed
Use of potentially inappropriate or “high risk” medications
Past or current toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Potential Drug-Induced Harm: Patient Factors

A

Age > 80 years old
Cognitive impairment
Multiple comorbidities
Multiple prescribers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prioritization of discontinuation

A
  1. Those with the likelihood of greatest harm and least benefit
  2. Those easiest to discontinue
  3. Those that the patient is most willing to discontinue first
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TTB

A

The time it takes for a medications effect to become evident in a population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TTH

A

The time until a significantly significant adverse effect is seen in a trial for the treatment group compared to the control group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TTB for bisphosphonates

A

8-19 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TTB for statins

A

2-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TTB for hypertension

A

1-2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TTB for aspirin

A

10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TTB for intensive glycemic control in diabetes

A

10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly